ReviewNPJ vaccines2024
Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors.
Review in NPJ vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Dual-antigen AdV5 vaccines against Crimean-Congo hemorrhagic fever virus induce superior humoral and Th1-biased cellular immunity.Scientific reports · 2026Article
- Seasonal Dynamics of Mosquito and Tick Vectors and Molecular Detection of Rift Valley Fever and Crimean-Congo Hemorrhagic Fever Viruses in Transboundary and Non-Transboundary Areas of Senegal.Tropical medicine and infectious disease · 2026Article
- Crimean-congo haemorrhagic fever virus in ticks and small ruminants in western Iran: epidemiological insights and genotyping.BMC infectious diseases · 2026Article
- Crimean-Congo Hemorrhagic Fever Virus in Africa: Epidemiological Trends, Transmission Ecology, Hotspot Heterogeneity, and Preparedness Challenges-A Narrative Review.Tropical medicine and infectious disease · 2026Review
- Crimean-congo hemorrhagic fever in Iraq, 2021-2024: epidemiological and clinical data analysis with proposed severity indicators for resource-constrained settings.BMC infectious diseases · 2026Article
- Discrimination of Hard Ticks by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).International journal of molecular sciences · 2025Article
- Genetic features of Orthonairovirus haemorrhagiae variants detected in ixodid ticks in Armenia.PLoS neglected tropical diseases · 2025Article
- Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmission.The Lancet regional health. Europe · 2025Review
- Review
- Crimean-Congo haemorrhagic fever in pregnancy: clinical outcomes and public health implications.Frontiers in public health · 2025Review
- Cocktail vaccine for the management ofFrontiers in immunology · 2024Article
- Investigation ofFrontiers in veterinary science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic disease associated with its principal tick vector, Hyalomma spp. with increasing fatal incidence worldwide. Accordingly, CCHF is a World Health Organization-prioritized disease with the absence of effective preventive interventions and approved vaccines or effective treatments. This perspective raised from a multidisciplinary gap analysis considering a One Health approach beneficial for human and animal health and the environment exploring international collaborations, gaps and recommendations.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.